References
- Szabo S, Trier J S, Frankel P W. Sulfhydryl compounds may mediate gastric cytoprotection. Science 1981; 214: 200–2
- New pharmacology of ulcer disease: experimental and new therapeutic approaches, S Szabo, Gy Mozsik. Elsevier, New York 1987
- Hunt T K, Knighton D R, Thakral K K. Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident activated wound macrophages. Surgery 1984; 96: 48–54
- Poulsen S S, Olsen P S, Kierkegaard P. Healing of cysteamineinduced duodenal ulcers in rat. Dig Dis Sci 1985; 30: 161–7
- Szabo S, Folkman J, Vattay P, . Duodenal ulcerogens: the effect of FGF on cysteamine-induced duodenal ulcer. Mechanisms of peptic ulcer healing, F Halter, A Garner, G NJ Tytgat, et al. Kluwer, London 1991; 139–50
- Szabo S, Folkman J, Vattay P, et al. Accelerated healing of duodenal ulcers by oral administration of a mutein of fibroblast growth factor in rats. Gastroenterology 1994; 106: 1106–11
- Koba H, Yamamoto R, Nakano H. History of the development of sucralfate. Dig Dis Sci 1990; 35: A10
- Hollander D, Tarnawski A. Protective effect of sucralfate on the gastric mucosa mediated by endogenous prostaglandins. New pharmacology of ulcer disease: experimental and new therapeutic approaches, S Szabo, G Mozsik. Elsevier, Amsterdam 1987; 404–412
- Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991; 214: 414–27
- Stovroff M, Vattay P, Marino B, Szabo S, Folkman J. Healing of experimental gastritis by oral fibroblast growth factor. Surg Forum 1991; 42: 174–5
- Szabo S, Kusstatscher S, Stovroff M. Role of bFGF and angiogenesis in ulcer healing and the treatment of gastritis. The stomach, W Domschke, S J Konturek. Springer- Verlag, Berlin/Heidelberg 1993; 193–7
- Szabo S. The mode of action of sucralfate: the 1 × 1 × 1 mechanism of action. Scand J Gastroenterol 1991; 26: 7–12